Previously, it was identified that Mapk10 (JNK3) could be inactivated in multiple lymphomas and carcinomas by epigenetic methylation, albeit only few studies have addressed this concern (Ying et al., 2006). This evidence concerns the gene MAPK10 and carcinoma.